Comparison

NKP-1339

Item no. DCC-DC9786-250mg
Manufacturer DCChemicals
CASRN 197723-00-5
Amount 250 mg
Quantity options 100 mg 10 mM x 1 mL in DMSO 1 g 250 mg
Category
Type Chemicals
Specific against other
Purity >98%
Smiles [Cl-][Ru+3]([N]1=CC2=CC=CC=C2N1)([Cl-])([Cl-])([N]3=CC4=CC=CC=C4N3)[Cl-].[Na+]
ECLASS 10.1 32160000
ECLASS 11.0 32160000
UNSPSC 12000000
Alias KP1339,KP 1339,NKP1339,NKP 1339,KP-1339
Similar products 197723-00-5
Available
Manufacturer - Applications
NKP-1339 is the first-in-class ruthenium-based anticancer drug in clinical development against solid cancer and has recently been studied successfully in a phase I clinical trial.
Storage Conditions
2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
Molecular Weight
502, 14

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 250 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close